Sign in

CIK 0001377121

  • Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980505495
Phone
+1 510-474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
  1. 4 Open-market sale President and CEO sold 48,273 shares at an average $84.18 ($4,063,743)
  2. 4 Open-market sale Chief Financial Officer sold 46,203 shares at an average $83.13 ($3,841,037)
  3. 4 Open-market sale Chief Medical Officer sold 23,151 shares at an average $82.30 ($1,905,305)
  4. 4 Open-market sale Chief Medical Officer sold 9,514 shares at $82.48 ($784,715)
  5. 4 Open-market sale President and CEO sold 34,438 shares at $82.48 ($2,840,446)
  6. 4 Open-market sale Chief Financial Officer sold 8,588 shares at $82.48 ($708,338)
  7. 4 Exercise or conversion Director acquired 14,299 shares (option exercise)
  8. 4 Grant or award Director acquired 2,695 shares (grant or award)
  9. 4 Grant or award Director acquired 2,695 shares (grant or award)
  10. 4 Grant or award Director acquired 2,695 shares (grant or award)
  11. 4 Grant or award Director acquired 2,695 shares (grant or award)
  12. 4 Grant or award Director acquired 2,695 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 95,400 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 25,600 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 25,600 shares (grant or award)
  16. 4 Gift President and CEO gave 440 shares (gift)
  17. 4 Open-market sale Chief Medical Officer sold 2,712 shares at $84.77 ($229,896)
  18. 4 Planned sale Director sold 12,000 shares at an average $81.62 ($979,480)
  19. 4 Planned sale Director sold 4,000 shares at $64.25 ($257,000)
  20. 4 Gift President and CEO gave 620 shares (gift)

Page 2 of 15 · 293 filings